News Sentiment

ARDT sentiment intelligence

Ardent Health Partners, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 55 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Care Facilities Read-through group
Latest close 10.08 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 55

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-6.3% over one week, +7.8% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction -6.3% Price reacting lower
Trend fit Trend active 7.8% over four weeks
Fair value -22.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 36
Negative 11

Relevance

Why the article matched

Direct first
Direct company coverage 55
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
Stock Titan 7
TradingKey 7
ACCESS Newswire 6
The Globe and Mail 3
TradingView 2
Moomoo 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 38
Earnings 6
Regulatory and legal 6
Analyst action 2
Guidance 1
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 55
Moomoo Direct company coverage

RBC Adjusts Price Target on Ardent Health Partners to $12 From $13, Maintains Outperform Rating

RBC Capital Markets has revised its price target for Ardent Health Partners to $12, down from the previous $13. Despite this adjustment, the firm has decided to maintain its Outperform rating on the company's stock. This indicates a continued positive outlook on Ardent Health Par

Tone
Neutral 50/100
Event
Analyst action
Published
09 Jul 2026 13:40
Source
Moomoo
Moomoo Direct company coverage

BofA Securities Adjusts Ardent Health Partners Price Target to $9.50 From $9

BofA Securities has updated its price target for Ardent Health Partners, increasing it to $9.50 from the previous $9. This adjustment reflects the firm's revised outlook on the healthcare provider.

Tone
Neutral 50/100
Event
Guidance
Published
08 Jul 2026 13:09
Source
Moomoo
Investing.com Canada Direct company coverage

Form 4 Ardent Health Partners LLC For: 2 July By Investing.com

This article announces the Form 4 filing for Ardent Health Partners LLC on July 2nd, emphasizing its significance in the stock market. It briefly mentions ARDT with a 6.22% increase and invites readers to view comments. The article itself is concise, serving primarily as a news f

Tone
Positive 61/100
Event
Market update
Published
03 Jul 2026 10:09
Source
Investing.com Canada
The Globe and Mail Direct company coverage

Ardent Health CEO Separation Agreement Finalizes Leadership Transition

Ardent Health Partners, Inc. announced that its President and CEO, Martin J. Bonick, departed from his roles and resigned from the Board of Directors effective June 2, 2026. A separation agreement, retroactively effective to June 2, 2026, grants Bonick severance benefits for term

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 10:40
Source
The Globe and Mail
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ardent Health, Inc. (NYSE:ARDT) securities. The firm encourages shareholders who bought shares prior to July 18, 2024, and continue to hold them, to contact them regarding a securities

Tone
Negative 29/100
Event
Regulatory and legal
Published
21 Jun 2026 21:40
Source
ACCESS Newswire
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Ardent Health, Inc. (ARDT) due to alleged corporate wrongdoing. The firm is encouraging shareholders who purchased Ardent securities prior to July 18, 2024, and still hold them, to join the investigation

Tone
Negative 28/100
Event
Regulatory and legal
Published
19 Jun 2026 16:11
Source
ACCESS Newswire
TradingKey Direct company coverage

Ardent Health Partners Inc (ARDT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Ardent Health Partners Inc (ARDT), noting a market cap of $1.45 billion and a P/E TTM of 10.63. It indicates that relevant data for business segment and regional revenue, including Q1-Q4 2025 and FY2023-2025, has not yet been disclose

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 09:10
Source
TradingKey
TradingKey Direct company coverage

Ardent Health Partners Inc (ARDT) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health analysis of Ardent Health Partners Inc (ARDT) dated June 18, 2026. The company has a current financial score of 7.09, ranking 51st in its industry, indicating stable financial status and high operating efficiency. It highlights a recent qu

Tone
Positive 67/100
Event
Market update
Published
18 Jun 2026 03:40
Source
TradingKey
TradingKey Direct company coverage

Ardent Health Partners Inc (ARDT) Shareholder Structure: Major Shareholders & Institutional Holdings

The article details the shareholder structure of Ardent Health Partners Inc (ARDT), listing its major shareholders and their proportions, including Chai Trust Company, Pure Health Holding PJSC, and Ventas Inc. It also breaks down shareholder types and provides institutional share

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 17:40
Source
TradingKey
TradingKey Direct company coverage

Ardent Health Partners Inc (ARDT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Ardent Health Partners Inc (ARDT). It states that no dividends have been distributed in the past five years and no stock split data is available. The page also displays current stock price, market capitaliz

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 17:40
Source
TradingKey
TradingKey Direct company coverage

Ardent Health Partners Inc (ARDT) Institutional Confidence

The article details the institutional confidence score for Ardent Health Partners Inc (ARDT), which is currently 7.00, ranking 37th in the Healthcare Providers & Services industry. Institutional shareholding decreased by 2.06% quarter-over-quarter, with HOTCHKIS & WILEY holding t

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 15:09
Source
TradingKey
TradingKey Direct company coverage

Ardent Health Partners Inc (ARDT) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Ardent Health Partners Inc (ARDT), noting its current valuation score of 9.18, which ranks 21st out of 76 in the Healthcare Providers & Services industry. It highlights the company's current P/E ratio of 9.54, indicating it is signifi

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 15:09
Source
TradingKey
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ardent Health, Inc. (ARDT) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Ardent Health, Inc. (ARDT). The firm encourages shareholders who purchased Ardent securities before July 18, 2024, and still hold them, to contact them to assist in the investi

Tone
Negative 29/100
Event
Regulatory and legal
Published
16 Jun 2026 11:00
Source
ACCESS Newswire
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Ardent Health, Inc. (NYSE: ARDT) regarding potential corporate wrongdoing by the company and its officers/directors. The firm is encouraging investors who purchased Ardent securities before July 18, 2024, and s

Tone
Negative 19/100
Event
Regulatory and legal
Published
14 Jun 2026 18:39
Source
ACCESS Newswire
ACCESS Newswire Direct company coverage

Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Ardent Health, Inc. (ARDT) for corporate wrongdoing involving its officers and/or directors. The firm is encouraging stockholders who purchased Ardent securities prior to July 18, 2024, and still hold th

Tone
Negative 26/100
Event
Regulatory and legal
Published
11 Jun 2026 19:38
Source
ACCESS Newswire
The Globe and Mail Direct company coverage

Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Tactile Systems Technology (TCMD) and Oric Pharmaceuticals (ORIC)

The article highlights bullish sentiments from financial analysts on three healthcare companies: Ardent Health Partners Inc. (ARDT), Tactile Systems Technology (TCMD), and Oric Pharmaceuticals (ORIC). UBS and Guggenheim reiterated Buy ratings for Ardent Health, William Blair main

Tone
Positive 72/100
Event
Market update
Published
08 Jun 2026 08:09
Source
The Globe and Mail
ACCESS Newswire Direct company coverage

Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Ardent Health, Inc. (ARDT). The firm is urging investors who purchased Ardent securities before July 18, 2024, and still hold them, to contact them to assist with the investiga

Tone
Negative 29/100
Event
Regulatory and legal
Published
07 Jun 2026 19:40
Source
ACCESS Newswire
Investing.com Canada Direct company coverage

Ardent Health Partners stock hits 52-week low at $7.93 By Investing.com

Ardent Health Partners stock recently hit a 52-week low of $7.93, though it has since recovered slightly to $8.34, still down over 36% year-over-year. Despite reporting a 7% increase in Q1 2026 revenue to $1.6 billion, its earnings per share missed expectations. InvestingPro anal

Tone
Negative 37/100
Event
Earnings
Published
07 Jun 2026 01:09
Source
Investing.com Canada